Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
6.00
+0.38 (6.76%)
Mar 26, 2026, 12:55 PM EDT - Market open
Zura Bio Market Cap
Zura Bio has a market cap or net worth of $569.28 million as of March 26, 2026. Its market cap has increased by 614.66% in one year.
Market Cap
569.28M
Enterprise Value
468.42M
1-Year Change
614.66%
Ranking
Category
Stock Price
$6.00
Market Cap Chart
Since September 3, 2021, Zura Bio's market cap has increased from $167.33M to $569.28M, an increase of 240.23%. That is a compound annual growth rate of 30.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 533.23M | 56.50% |
| Dec 31, 2025 | 340.72M | 108.73% |
| Dec 31, 2024 | 163.23M | -19.82% |
| Dec 29, 2023 | 203.58M | 15.59% |
| Dec 30, 2022 | 176.12M | 3.44% |
| Dec 31, 2021 | 170.26M | 1.75% |
| Sep 3, 2021 | 167.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| YD Bio | 543.57M |
| Allogene Therapeutics | 538.75M |
| DBV Technologies | 537.32M |
| Zevra Therapeutics | 537.21M |
| CorMedix | 510.67M |
| ADC Therapeutics | 500.55M |
| Nautilus Biotechnology | 498.91M |
| Rigel Pharmaceuticals | 482.70M |